A Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of N-Rephasin® SAL200 in Healthy Male Volunteers

NCT01855048 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers
Anti-Bacterial Agents
Methicillin-Resistant Staphylococcus Aureus

Interventions

BIOLOGICAL: N-Rephasin® SAL200
OTHER: INT200-Placebo

Sponsor

Intron Biotechnology, Inc.